Beta version (currently under testing). If you would like to visit the old website, click here.

Enzymology external website

Enzymology Department

Enzymology

The central research topic of the group is the study of the structure-function relationships of signaling enzymes, with emphasis on tyrosine phosphatase proteins. We aim to contribute to the understanding of how their structural characteristics are correlated with specific signaling functions. To this end, we analyze each signaling enzyme that we investigate from several directions:

  •          as a classical enzyme, trying to evaluate its stability under different conditions, pH dependence of activity, specific activity, kinetic parameters at steady state, substrate specificity and also the identification of specific inhibitors as well as the corresponding inhibition constants;
  •          as a protein, trying to crystallize the purified enzyme preparation and then determine its 3D structure
  •          as a signaling entity, trying to find its subcellular location, physiological substrate (s), regulatory interactions, the role played in signaling pathways, etc.

The combination of results thus obtained in this way is further used to shed light on the signaling mechanism and the overall functional role of the given enzyme.

The group has good experience and is currently involved in the production, isolation and purification of recombinant proteins, expressed in both prokaryotic and eukaryotic systems. The research activity of the group is performed by molecular biology instruments (recombinant DNA, site-directed mutagenesis, (RT) -PCR, Western blot, immunoprecipitation, etc.), spectroscopic analysis (UV-VIS and fluorescence spectrophotometry), cell biology, protein crystallization and enzyme kinetic analysis.

Our team is involved in numerous national research projects and international collaborations.

Thus, the specific research projects in progress are:

  •          Identification of signaling mechanisms involved in tumorigenesis, as a result of dephosphorylation by EYA3 of the specific substrate WDR1;
  •          Study of the mechanism of action of some interference peptides involved in inhibiting the internalization of AMPA neuronal receptors;
  •          Identification of new tumor markers in acute myeloid leukemia, thyroid cancer, lung cancer, colorectal cancer. Potential ways of targeted diagnosis;
  •           Design and laboratory experimentation of a molecular vector based on Holmium166 for targeted radiodiagnosis and radiotherapy.

·  Research Grant 548PED/2020-2022 from UEFISCDI for "Development of a functional model of a neutron activator (NA) controlled by a cyclotron to obtain a radiopharmaceutical based on an affibody coupled to a surface of activated nanoparticles", Partner (P) team, PN-III-P2-2.1-PED-2019-4184;

Project team: Partner Project Manager: Dr.Szedlacsek Stefan Eugen, Researcher: Dr.Szedlacsek Horea Stefan, PhD Student: Puiu Adina Gabriela, PhD Student: Vasilescu Andrei- Mihai

·  Research Grant 35PCCDI/2018-2021 from UEFISCDI for „Genomic mapping of population in area contaminated with radioactivity and heavy metals”, Partner 3, PN-III-P1-1.2-PCCDI-2017-0737;

Project team: Partner Project Manager: Dr.Szedlacsek Stefan Eugen, Researcher: Dr. Ionescu Aura-Elena, Research assistant: Dr.Szedlacsek Horea Stefan, PhD Student: Puiu Adina-Gabriela, PhD Student: Vasilescu Andrei-Mihai, Assistant technician: Donțu Otilia Cristina.

 

·  Research Grant 64PCCDI/2018-2021 from UEFISCDI for „Development of radio-pharmaceuticals and nuclear technics in oncology for imaging and personalized therapy at molecular level”, Partner 1, PN-III-P1-1.2-PCCDI-2017-0769;

Project team: Partner Project Manager: Dr.Szedlacsek Stefan Eugen, Researcher: Dr. Badea Rodica-Aura, PhD Student Bănică Alexandra Maria, Assistant technician: Bică Cătălin-Constantin

In Fig.8.1: Atributul de biomarker in leucemia acuta pe celule mieloide monocitare MLL-AF9 al Ly6C

 

 

1. Experiment-based design of lead compounds with potential cognitive enhancement effect

  • Dr Rodica Badea
  • Dr Horea Szedlacsek

The decline of cognitive capacity is one of the most debilitating features of neurodegenerative diseases. To a great extent, this is due to changes in the molecular composition of postsynaptic membranes which in turn leads to reduced synaptic plasticity. Synaptic function depends on synaptic plasticity which can either potentiate or depress information transfer. As a rule, high-frequency stimulation potentiates synaptic activity leading to long-term potentiation (LTP) while low-frequency stimulation depresses synaptic activity leading to long-term depression (LTD). Long term changes in synaptic functions can be induced by activation of NMDA receptors which modify synaptic strength through regulating the number of postsynaptic AMPA receptors (AMPAR). NMDAR activation leads to Ca2+ influx through the receptor coupled ion channel which can initiate either LTP or LTD, depending on the spatiotemporal activation profile. Cognitive impairment and learning ability of the brain is directly linked to synaptic plasticity as measured in LTP changes in animal models of brain diseases.

AMPARs are glutamate-activated ion channels which mediate the fast excitatory ion current underlying information transmission in the brain. An increase in the number of postsynaptic AMPARs leads to increased synaptic strength during LTP, while a decrease in postsynaptic AMPAR number produces LTD. Increased number of AMPAR during LTP can be mediated by both exocytosis of AMPARs and/or lateral diffusion of AMPARs from the peri-synaptic membrane to the synapse. Conversely, LTD leads to AMPAR diffusion away from the synapse and receptor endocytosis.

Post-translational modifications of AMPAR cytoplasmic region like tyrosine phosphorylation were proved to play important role in receptor trafficking and other processes so that a specific phosphorylation pattern of this receptor might be associated with a physiological or pathological state. The main idea of this project is to modulate the phosphorylation state of AMPA receptors in such a manner to favor a physiological functionality of the receptor. Eventually, we aim at identifying lead compounds with potential cognitive enhancement effect.

2. Mapping of tyrosine phosphorylation sites and functional analysis of EYA 3

  • Dr.Aura Ionescu
  • PhD Adina Gabriela Puiu

Eyes absent (eya) proteins are members of a regulatory network of evolutionary conserved transcription factors and cofactors, termed retinal determination gene network (RDGN) in Drosophila, along with twin of eyeless (toy), eyeless (ey), sine oculis (so) and dachshund (dac). From insects to humans, there are correspondent gene families - Pax (for toy and ey), Six (for so), Eya (for eya) and Dach (for dac) - referred to as the PSEDN (Pax-Six-Eya-Dach) network. This network holds important roles in the development and homeostasis of various tissues and organs - eyes, kidneys, nervous system, ears, muscles - as well as in the context of limb formation, gonadogenesis and neurogenesis. Loss of function mutations in the Eyes absent genes can lead to several congenital syndromes, for example cardiofacial syndrome, bronchio-oto-renal syndrome, oto-facio-cervical syndrome, congenital cataract, late onset of deafness. On the other hand, overexpression of Eyes absent has been detected in diverse types of cancers like epithelial ovarian cancer, Wilms’ tumors, lung adenocarcinoma, colorectal cancer, colon cancer, esophageal adenocarcinoma.

Post-translational modifications of EYA proteins may influence their implication in physiological and pathological events. Recently, we have demonstrated and reported that Src kinase phosphorylates human EYA1 and EYA3 and their nuclear and cytoskeletal localization are controlled by Src phosphorylation. In the same time, we have found that EYA1 and EYA3 are capable of autodephosphorylation. We have also shown that Src kinase has phosphorylation sites in both N-terminal and C-terminal domains of EYA3 protein. This data brings into discussion the implication of tyrosine phosphorylation in regulating the physiological activities of eyes absent proteins and potential interacting partners in mammalian cells. Thus, in this project we perform a detailed mass spectrometric analysis of human EYA3 phosphorylation by protein tyrosine kinase Src and analyze whether the phosphorylation sites can be autodephosphorylated. In terms of our future objectives we plan to identify the physiological impact of the phosphorylation of the detected tyrosine residues.

3. Identification of signaling mechanisms involved in tumorigenesis, as a result of EYA3 dephosphorylation of the specific substrate WDR1.

  • Dr. Aura Ionescu
  • PhD Adina Gabriela Puiu
  • PhD Andrei Mihai Vasilescu

Eyes Absent protein 3 (EYA3), active c-Src, WDR1 as well as tyrosine phosphorylated form of WDR1 have been reported as playing important roles in breast cancer initiation, progression and metastasis. It has been also shown that protein tyrosine phosphatase activity of EYA3 mediates breast cancer cell migration, invasion, transformation and metastasis through an as yet unidentified mechanism. Our recently reported findings indicate that WDR1, a significant mediator of actin cytoskeleton reorganization i) is phosphorylated by active c-Src, ii) is an in vitro cytoplasmic substrate of EYA3 and iii) its dephosphorylation by EYA3 generates major changes to the cellular actin cytoskeleton. The central task of the present project is the in vivo validation of WDR1 dephosphorylation by EYA3 and identification of the downstream pathways. Initially, we will assess how the expression of EYA3, c-Src, WDR1 and the Tyr phosphorylation level of WDR1 correlate with the tumor-promoting effects in several representative breast cancer cell lines, what are WDR1/EYA3 interactors and what molecular mechanism(s) underly the identified correlations and interactions. Moreover, we wish to shed light on how the dephosphorylation of WDR1 by EYA3 is connected to Rho GTPase signaling pathways. Finally, we aim to elucidate the involvement of in vivo dephosphorylation of WDR1 by EYA3 in the tumorigenic properties of breast cancer cells using subcutaneous xenografted mice.

4. Design and laboratory experimentation of a molecular vector based on Holmium166 for re-diagnosis and targeted radiotherapy.

  • Dr. Szedlacsek Horea
  • PhD Adina Gabriela Puiu
  • PhD Andrei Mihai Vasilescu

Our project is structured on three distinct panels of experimental development and applied research and has as final result the realization of a functional model of a neutron activator (NA) controlled by a cyclotron, to obtain a radiopharmaceutical based on an antibody coupled to an activated nanoparticle surface; the nanoparticles contain radionuclide that emits β Holmium-166 (t1 / 2 = 26.8 h), a type of radiation proven to be effective for targeted cancer therapy.

Financial resources:

·   Research Grant 548PED/2020-2022 from UEFISCDI for "Development of a functional model of a neutron activator (NA) controlled by a cyclotron to obtain a radiopharmaceutical based on an affibody coupled to a surface of activated nanoparticles", Partner (P) team, PN-III-P2-2.1-PED-2019-4184;

·  Research Grant 35PCCDI/2018-2021 from UEFISCDI for „Genomic mapping of population in area contaminated with radioactivity and heavy metals”, Partner 3, PN-III-P1-1.2-PCCDI-2017-0737;

·    Research Grant 64PCCDI/2018-2021 from UEFISCDI for „Development of radio-pharmaceuticals and nuclear technics in oncology for imaging and personalized therapy at molecular level”, Partner 1, PN-III-P1-1.2-PCCDI-2017-0769;

 

 

Stefan Szedlacsek, Dr.
Stefan Szedlacsek, Dr.

Head of Department

Professor Dr. Stefan Eugen Szedlacsek is the Head of the Enzymology Department at the Institute of Biochemistry of the Romanian Academy. He holds a PhD degree in Biotechnology from Polytechnic University of Bucharest as well as a MSc in Organic Synthesis (Polytechnic University- Bucharest) and MSc in Mathematics (Bucharest University). As a visiting scientist, he performed research in the field of cholesterol metabolism University of Illinois at Urbana-Champaign (USA), where he succeeded to evidence a new pathway in the metabolism of oxysterols. He is an “Alexander von Humboldt“ fellow and worked in Germany, in the Institute of Biochemistry (Kiel University) More...

Alexandra Bănică
Alexandra Bănică

PhD Student, Research Assistant

Alexandra Bănică is a researcher in the Institute of Biochemistry of the Romanian Academy. Alexandra is currently working in Enzymology in the Enzymology.

Aura-Elena Ionescu, PhD student
Aura-Elena Ionescu, PhD student

Scientific Researcher

Born: 19th of November 1988, Ploiesti, Romania 2003 - 2007: „Ion Luca Caragiale” National College, Ploieşti, Romania 2007- 2012: Faculty of Pharmacy at University of Medicine and Pharmacy "Carol Davila" Bucharest 2012 More...

Carmen Alexandra Tanase, Dr.
Carmen Alexandra Tanase, Dr.

Researcher

Ph.D. University of Missouri-Kansas City, Dept. Molecular Biology and Biochemistry, 2001. Protein import into mitochondria Post-doc. Kansas University-Medical Center, Dept. Cell Biology and Anatomy, 2001-2004. Role of e More...

Horea Szedlacsek
Horea Szedlacsek

Research Assistant

Horea Szedlacsek is a researcher in the Institute of Biochemistry of the Romanian Academy. Horea is currently working in Enzymology in the Enzymology.

Otilia-Cristina Donțu, Ms.
Otilia-Cristina Donțu, Ms.

Trainee Assistant

Otilia-Cristina Donțu is a researcher in the Institute of Biochemistry of the Romanian Academy. Otilia-Cristina is currently working in Enzymology in the Enzymology.

Rodica-Aura Badea, Dr.
Rodica-Aura Badea, Dr.

Scientific Researcher

Rodica-Aura Badea is a researcher in the Institute of Biochemistry of the Romanian Academy. Rodica-Aura is currently working in Enzymology in the Enzymology.

Sorin Tunaru, Dr.
Sorin Tunaru, Dr.

Scientific Researcher

Sorin Tunaru is a researcher in the Institute of Biochemistry of the Romanian Academy. Sorin is currently working in Enzymology in the Enzymology.

Viorel Enache, MSc.
Viorel Enache, MSc.

Research Assistant

Viorel Enache is a researcher in the Institute of Biochemistry of the Romanian Academy. Viorel is currently working in Enzymology in the Enzymology.

Year

RECENT PUBLICATIONS

1.Analysis of EYA3 Phosphorylation by Src Kinase Identifies Residues Involved in Cell Proliferation.

Ionescu AE, Mentel M, Munteanu CVA, Sima LE, Martin EC, Necula-Petrareanu G, Szedlacsek SE.

Int J Mol Sci. 2019 Dec 13;20(24). pii: E6307. doi: 10.3390/ijms20246307.

 

2. Regulation of TRPM8 channel activity by Src-mediated tyrosine phosphorylation.

Manolache A, Selescu T, Maier GL, Mentel M, Ionescu AE, Neacsu C, Babes A, Szedlacsek SE.

J Cell Physiol. 2019 Nov 14. doi: 10.1002/jcp.29397. Published: June 2020

 

3. Biological and molecular modifications induced by cadmium and arsenic during breast and prostate cancer

    development.

Zimta AA, Schitcu V, Gurzau E, Stavaru C, Manda G, Szedlacsek S, Berindan-Neagoe I. Environ Res. 2019, Nov;178:108700. doi: 10.1016/j. Review.

 

4.    Crystal structure of a xylulose 5-phosphate phosphoketolase. Insights into the substrate specificity for xylulose 5-phosphate.

      Scheidig AJ, Horvath D, Szedlacsek SE. J Struct Biol. 2019 Jul 1;207(1):85-102.

 

 

5.    Collagen regulates the ability of endothelial progenitor cells to protect hypoxic myocardium through a mechanism involving miR-377/VE-PTP axis.

Rosca AM, Mitroi DN, Cismasiu V, Badea R, Necula-Petrareanu G, Preda MB, Niculite C, Tutuianu R, Szedlacsek SE, Burlacu A. J.Cell.Mol.Med., 2018, 22(10), 4700-4708

 

6.      WDR1 is a novel EYA3 substrate and its dephosphorylation induces modifications of the cellular actin cytoskeleton.

Mentel M, Ionescu AE, Puscalau-Girtu I, Helm MS, Badea RA, Rizzoli SO, Szedlacsek SE. Sci Rep. 2018 Feb 13;8(1):2910.

 

7.      20-HETE promotes glucose-stimulated insulin secretion in an autocrine manner through FFAR1.

Tunaru S, Bonnavion R, Brandenburger I, Preussner J, Thomas D, Scholich K, Offermanns S. Nat Commun. 2018 Jan 12;9(1):177.

 

8.      Dysregulation of lysophosphatidic acids in multiple sclerosis and autoimmune encephalomyelitis.

Schmitz K, Brunkhorst R, de Bruin N, Mayer CA, Häussler A, Ferreiros N, Schiffmann S, Parnham MJ, Tunaru S, Chun J, Offermanns S, Foerch C, Scholich K, Vogt J, Wicker S, Lötsch J, Geisslinger G, Tegeder I. Acta Neuropathol Commun. 2017 Jun 2;5(1):42.

 

9.      The G2A receptor (GPR132) contributes to oxaliplatin-induced mechanical pain hypersensitivity.

Hohmann SW, Angioni C, Tunaru S, Lee S, Woolf CJ, Offermanns S, Geisslinger G, Scholich K, Sisignano M. Sci Rep. 2017 Mar 27;7(1):446.

 

10.  The leukotriene B4 receptors BLT1 and BLT2 form an antagonistic sensitizing system in peripheral sensory neurons.

Zinn S, Sisignano M, Kern K, Pierre S, Tunaru S, Jordan H, Suo J, Treutlein EM, Angioni C, Ferreiros N, Leffler A, DeBruin N, Offermanns S, Geisslinger G, Scholich K. J Biol Chem. 2017 Apr 14;292(15):6123-6134.

 

11.   Expression, Purification, and Kinetic Analysis of PTP Domains.

Mentel M, Badea RA, Necula-Petrareanu G, Mallikarjuna ST, Ionescu AE, Szedlacsek SE. Methods Mol Biol. 2016;1447:39-66.

 

12.    Arachidonic Acid Metabolite 19(S)-HETE Induces Vasorelaxation and Platelet Inhibition by Activating Prostacyclin (IP) Receptor.

Tunaru S, Chennupati R, Nüsing RM, Offermanns S. PLoS One. 2016 Sep 23;11(9):e0163633.

 

13.  Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes.

Tang C, Ahmed K, Gille A, Lu S, Gröne HJ, Tunaru S, Offermanns S. Nat Med. 2015 Feb;21(2):173-7.

 

14.  Phosphoketolases from Lactococcus lactis, Leuconostoc mesenteroides and Pseudomonas aeruginosa: dissimilar sequences, similar substrates but distinct enzymatic characteristics.

Petrareanu G, Balasu MC, Vacaru AM, Munteanu CV, Ionescu AE, Matei I, Szedlacsek SE. Appl Microbiol Biotechnol. 2014 Sep;98(18):7855-67.

 

15.  A novel luminescence-based method for the detection of functionally active antibodies to muscarinic acetylcholine receptors of the M3 type (mAchR3) in patients' sera.

Preuss B, Tunaru S, Henes J, Offermanns S, Klein R. Clin Exp Immunol. 2014 Jul;177(1):179-89.

 

16.  Conserved MIP receptor-ligand pair regulates Platynereis larval settlement.

Conzelmann M, Williams EA, Tunaru S, Randel N, Shahidi R, Asadulina A, Berger J, Offermanns S, Jékely G. Proc Natl Acad Sci U S A. 2013 May 14;110(20):8224-9.

 

17.  Protein tyrosine phosphatase structure-function relationships in regulation and pathogenesis.

Böhmer F, Szedlacsek S, Tabernero L, Ostman A, den Hertog J. FEBS J. 2013 Jan;280(2):413-31.

 

18.  Castor oil induces laxation and uterus contraction via ricinoleic acid activating prostaglandin EP3 receptors.

Tunaru S, Althoff TF, Nüsing RM, Diener M, Offermanns S. Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):9179-84.

 

 

 

 

 

 

 

 

Compound for inhibition of certain signaling processes related to the evolution of the cognitive processes 2017-2018
Acronym: Ctr.327/27.03.2017/Company CRU SRL, Medical Services Company/ Dunakesz, Hungary
Budget: 70.000 euro
Project director: Stefan Szedlacsek

Molecular modeling of a set of peptides that can disrupt the GluA2-Cterm complex with STEP (Complex A) or BRAG2 (ComplexB).

Compound for inhibition of certain signaling processes related to the evolution of the cognitive processes
Novel radiolabeled affibodies for targeted imaging and therapy 2019-2021
Acronym: Bilateral agreement no.3698/13.09.2018 Romanian Academy- Hungarian Academy of Sciences
Project director: Stefan Szedlacsek

The project is agreed as a joint collaboration among IBAR and ATOMKI, UD and IFIN-HH is a cost free participant. There are two main directions envisaged by the proposed project: receptors mapping and therapy, using an affibody against HER2 receptor, combined with an adequate radioisotope. In this respect, the specific objectives are: a) expression and purification of affibodies; b) establish labeling procedures; c) ex vivo and/or in vivo testing of optimal compounds.

Structure, Regulation, and Biological Function 2007-2011
Acronym: PTPNET
Budget: 145.231,18 euro
Project director: Stefan Szedlacsek

Enzymatic characterization of both mEya3 and hEya1 to identify the similarities and differences between these two proteins with relatively low sequence homology.

Structure, Regulation, and Biological Function
“Reconstruction of Ancestor of Receptor Protein Tyrosine Phosphatase Catalytic” 2011-2016
Acronym: PN-II-ID-PCE-2011-3-0743
Budget: 1499990
Project director: Stefan Szedlacsek

Synthesis of the catalytic domain of ancestral PTP and its characterization both in vitro and in vivo.